Consortium Members
A consortium agreement was inked on 16 October 2018 between the òòò½Íø, Technology and Research (A*STAR), National University of òòò½Íø(NUS), Nanyang Technological University, òòò½Íø(NTU Singapore), òòò½ÍøInstitute of Technology (SIT) and three major pharmaceutical MNCs, i.e. GlaxoSmithKline (GSK), MSD International GmbH (òòò½Íøbranch) and Pfizer Asia Pacific. They are also the founding members of PIPS. Syngenta Crop Protection AG (Syngenta) joined the consortium in December 2019 as the 4th core member. A world-leading agrochemicals company, Syngenta uses manufacturing technologies almost identical to pharmaceutical small molecule API processing and is very keen to share their experience and learn from PIPS. In addition, PIPS comprises academic partners from Cambridge Centre for Advanced Research and Education in òòò½Íø(CARES), NUS, NTU Singapore, SIT, Singapore-MIT Alliance for Research and Technology (SMART), òòò½ÍøPolytechnic (SP) and SUTD.
The Extended Team is a diverse group consisting pharmaceutical supply chain, technology, consultancy, training and engineering companies, including SMEs and LLEs invited by the core members to participate in specific projects. They include the following companies.
.png?sfvrsn=d28bf510_1 "Paeonia")
Note: Companies are listed in alphabetical order.
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.